Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yagil

Showing results (11-20 of 909) with videos related to

Pageof 91
Sort By:
Hypertension (Dallas, Tex. : 1979)|October 3, 2007
Peroxisome proliferator-activated receptor alpha: friend or foe?Chana Yagil, Yoram Yagil
Harefuah|May 23, 2017
[THE ISRAELI RAT GENOME CENTER]Yoram Yagil, Chana Yagil
Journal of Hypertension|November 14, 1998
Does the Sabra hypertension-prone rat represent a model of salt or mineralocorticoid sensitivity?Y Yagil, C Yagil
Journal of Hypertension|November 5, 2003
Congenics in the pathway from quantitative trait loci detection to gene identification: is that the way to go?Yoram Yagil, Chana Yagil
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Genomic research in rat models of kidney diseaseYoram Yagil, Chana Yagil
Experimental Nephrology|October 29, 2000
Genetic models of hypertension in experimental animalsY Yagil, C Yagil
Pharmacogenomics|April 30, 2003
Pharmacogenomic considerations for immunosuppressive therapyYoram Yagil, Chana Yagil
Journal of Hypertension|June 18, 2004
Candidate genes, association studies and haplotype analysis in the search for the genetic basis of hypertensionYoram Yagil, Chana Yagil
Trends in Cardiovascular Medicine|February 14, 2006
Integration--a key to success in the genetic dissection of complex diseases?Yoram Yagil, Chana Yagil
Transplant Immunology|August 16, 2002
Insights into pharmacogenomics and its impact upon immunosuppressive therapyYoram Yagil, Chana Yagil
Pageof 91

Showing results (11-20 of 909) with videos related to

Sort By:
Pageof 91
Hypertension (Dallas, Tex. : 1979)|October 3, 2007
Peroxisome proliferator-activated receptor alpha: friend or foe?Chana Yagil, Yoram Yagil
Harefuah|May 23, 2017
[THE ISRAELI RAT GENOME CENTER]Yoram Yagil, Chana Yagil
Journal of Hypertension|November 14, 1998
Does the Sabra hypertension-prone rat represent a model of salt or mineralocorticoid sensitivity?Y Yagil, C Yagil
Journal of Hypertension|November 5, 2003
Congenics in the pathway from quantitative trait loci detection to gene identification: is that the way to go?Yoram Yagil, Chana Yagil
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Genomic research in rat models of kidney diseaseYoram Yagil, Chana Yagil
Experimental Nephrology|October 29, 2000
Genetic models of hypertension in experimental animalsY Yagil, C Yagil
Pharmacogenomics|April 30, 2003
Pharmacogenomic considerations for immunosuppressive therapyYoram Yagil, Chana Yagil
Journal of Hypertension|June 18, 2004
Candidate genes, association studies and haplotype analysis in the search for the genetic basis of hypertensionYoram Yagil, Chana Yagil
Trends in Cardiovascular Medicine|February 14, 2006
Integration--a key to success in the genetic dissection of complex diseases?Yoram Yagil, Chana Yagil
Transplant Immunology|August 16, 2002
Insights into pharmacogenomics and its impact upon immunosuppressive therapyYoram Yagil, Chana Yagil
Pageof 91